Top Midday Gainers

MT Newswires Live11-20

Interactive Strength (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.

More than 24.4 million shares traded intraday compared with a daily average of about 146,000.

Piper Sandler upgraded Aclaris Therapeutics (ACRS) to overweight with a price target of $13.

The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.

Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.

Invizyne Technologies (IZTC) said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.

Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.

Price: 3.31, Change: +0.78, Percent Change: +30.83

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484974965?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-20 03:19","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484974965","market":"us","top_or_hot":-1,"title":"Top Midday Gainers","media":"MT Newswires Live","content":"<html><body><p> <a href=\"https://laohu8.com/S/TRNR\">Interactive Strength</a> (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.</p><p>More than 24.4 million shares traded intraday compared with a daily average of about 146,000.</p><p>Piper Sandler upgraded <a href=\"https://laohu8.com/S/ACRS\">Aclaris Therapeutics</a> (ACRS) to overweight with a price target of $13.</p><p>The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.</p><p>Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.</p><p>Invizyne Technologies (IZTC) said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.</p><p>Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.</p><p>Price: 3.31, Change: +0.78, Percent Change: +30.83</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Top Midday Gainers</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTop Midday Gainers\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-20 03:19 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Interactive Strength (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.More than 24.4 million shares traded intraday compared with a ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4007","symbol_name":"制药","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2484974965","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484974965","pubTimestamp":1732043951,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Interactive Strength  shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.More than 24.4 million shares traded intraday compared with a daily average of about 146,000.Piper Sandler upgraded Aclaris Therapeutics  to overweight with a price target of $13.The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.Invizyne Technologies  said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.Price: 3.31, Change: +0.78, Percent Change: +30.83","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK4007":"制药","ACRS":"Aclaris Therapeutics","TRNR":"Interactive Strength","BK4190":"消闲用品"},"translate_title":"午盘涨幅最大的股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ACRS":0.9,"TRNR":0.9},"content_text":"Interactive Strength (TRNR) shares soared 31% after the company unveiled Tuesday CLMBR fitness equipment installations in Saudi Arabia.More than 24.4 million shares traded intraday compared with a daily average of about 146,000.Piper Sandler upgraded Aclaris Therapeutics (ACRS) to overweight with a price target of $13.The move comes as Aclaris said it acquired global development rights outside of China for potential anti-TSLP monoclonal and bispecific antibodies directed against both TSLP and IL4R developed by Chinese biotech firm Biosion.Shares of Aclaris catapulted 50% as intraday trading volume soared to more than 48.4 million from a daily average of about 1.03 million.Invizyne Technologies (IZTC) said Tuesday that it received a $2 million project to enable enzyme production for cell-free biomanufacturing of sustainable aviation fuel.Shares jumped 12%, with intraday trading volume at over 10,400 compared with a daily average of about 45,000.Price: 3.31, Change: +0.78, Percent Change: +30.83","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484974965"}